Acadia Pharmaceuticals buy Needham & Company LLC
Start price
28.02.24
/
50%
€21.60
Target price
28.02.25
€33.24
Performance (%)
-27.71%
Price
26.04.24
€15.62
Summary
This prediction is currently active. The price of Acadia Pharmaceuticals has decreased since the start of the prediction. Compared to the start price this results in a performance of -27.71%. This prediction currently runs until 28.02.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Acadia Pharmaceuticals | -2.131% | -2.131% |
| iShares Core DAX® | 0.961% | -2.210% |
| iShares Nasdaq 100 | 2.626% | -1.918% |
| iShares Nikkei 225® | 0.217% | -7.216% |
| iShares S&P 500 | 1.540% | -1.858% |
Comments by Needham___Company_LL for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at Needham & Company LLC from $37.00 to $36.00. They now have a "buy" rating on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Needham___Company_LL for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€16.56
09.04.24
09.04.24
€29.40
09.04.25
09.04.25
-3.29%
26.04.24
26.04.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€18.20
12.03.24
12.03.24
€29.32
12.03.25
12.03.25
-14.20%
26.04.24
26.04.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€24.80
24.01.24
24.01.24
€33.86
24.01.25
24.01.25
-35.44%
26.04.24
26.04.24